|
 |
| |
|
Æä½ºÄÚÇÇÇÏÁÖ»ç600/600mg(ÆÛÅõÁÖ¸¿/Æ®¶ó½ºÅõÁÖ¸¿) 10mL Pesco S.C. Inj. 600/600mg
|
|
Àü¹®ÀǾàǰ | ±Þ¿©
|
|
¼öÀÔÀǾàǰ
|
| |
 |
¾Ë¸²: |
µå·°ÀÎÆ÷¿¡¼´Â ÀǾàǰ ÀÎÅÍ³Ý ÆÇ¸Å¸¦ ÇÏÁö ¾Ê½À´Ï´Ù. |
|
|
|
Àü¹®/ÀÏ¹Ý |
Àü¹®
|
|
|
|
| ¹«»ö³»Áö ¿¶Àº Ȳ»öÀÇ ¾×ü°¡ ÃæÀüµÈ ¹«»öÅõ¸íÇÑ ¹ÙÀÌ¾Ë ÁÖ»çÁ¦ |
|
|
|
|
|
Á¦Á¶È¸»ç |
(ÁÖ)Çѱ¹·Î½´
|
ÆÇ¸Åȸ»ç |
(ÁÖ)Çѱ¹·Î½´
|
Çã°¡Á¤º¸ |
Á¤»ó
(2021.09.06)
|
BIT ¾àÈ¿ºÐ·ù |
Ç¥ÀûÄ¡·á Ç×¾ÏÁ¦(Targeted cancer therapy)
|
º¹ÁöºÎºÐ·ù |
421[Ç׾ǼºÁ¾¾çÁ¦ ] |
û±¸ÄÚµå(KDÄÚµå) ºñ±Þ¿©Á¡°ËÄÚµå |
645001541 \3,490,410 ¿ø/10mL/º´(2024.08.01)(ÇöÀç¾à°¡)
|
|
|
ATCÄÚµå |
pertuzumab and trastuzumab / L01FY01 |
NDCÄÚµå |
[Proprietary Name Search _ ƯÇãµî·Ï¸í,»óÇ¥¸íÀ¸·Î °Ë»ö]
[Active Ingredient Search _ ÁÖ¼ººÐÀ¸·Î °Ë»ö]
[NDC Number Search _ NDCÄÚµå·Î °Ë»ö]
|
¼ººÐ / ÇÔ·® |
[½ÉÆò¿ø ÁÖ¼ººÐÄÚµå ±âÁØ ¼ººÐÇÔ·®Á¤º¸ Á¶È¸]

|
÷°¡Á¦ |
¹é´ç,
¾ËÆÄ-¾ËÆÄ-Æ®·¹ÇҷνºÀ̼öȹ°,
ÀçÁ¶ÇÕÀΰ£È÷¾Ë·ç·Î´Ï´ÙÁ¦,
ÁÖ»ç¿ë¼ö,
Æú¸®¼Ò¸£º£ÀÌÆ®20,
L-¸ÞƼ¿À´Ñ,
L-È÷½ºÆ¼µò,
L-È÷½ºÆ¼µò¿°»ê¿°Àϼöȹ°
|
|
|
|
|
 |
|
|
|
|
|
| Ç× ¸ñ |
³» ¿ë |
|
|
| |
ÃÖ±ÙÁ¤º¸¼öÁ¤ÀÏ 2025-09-07 |
|
|
|
|
| |
|
|
|